A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma.
A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma.
复制标题
DOI:
10.1002/ijc.33828
复制
发表时间:
2022-02-01
影响因子:
6.4
通讯作者:
Izumchenko E
中科院分区:
文献类型:
--
作者:
Ghantous Y;Omar M;Broner EC;Agrawal N;Pearson AT;Rosenberg AJ;Mishra V;Singh A;El-Naaj IA;Savage PA;Sidransky D;Marchionni L;Izumchenko E
Oral cavity squamous cell carcinoma (OSCC) affects more than 30,000 individuals in the US annually, with smoking and alcohol consumption being the main risk factors. Management of early stage tumors usually includes surgical resection followed by postoperative radiotherapy in certain cases. The cervical lymph nodes (LN) are the most common site for local metastasis and elective neck dissection is usually performed if the primary tumor thickness is greater than 3.5 mm. However, postoperative histological examination often reveals that many patients with early stage disease are negative for neck nodal metastasis, posing a pressing need for improved risk stratification to either avoid over-treatment or prevent the disease progression. To this end, we aimed to identify a primary tumor gene signature that can accurately predict cervical LN metastasis in patients with early stage OSCC. Using gene expression profiles from 189 samples, we trained K-top scoring pairs (K-TSPs) models and identified six gene pairs that can distinguish primary tumors with nodal metastasis from those without metastasis. The signature was further validated on an independent cohort of 35 patients using RT-PCR in which it achieved an Area Under the ROC Curve (AUC) and accuracy of 90% and 91% respectively. These results indicate that such signature holds promise as a quick and cost effective method for detecting patients at high risk of developing cervical LN metastasis, and may be potentially used to guide the neck treatment regimen in early-stages OSCC.
登录
查看更多内容
影响因子:
5.8
作者:
Liberzon, Arthur;Subramanian, Aravind;Mesirov, Jill P.
通讯作者:
Mesirov, Jill P.
DOI:
10.1007/s00405-020-06538-y
发表时间:
2021-09
期刊:
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
影响因子:
--
作者:
de Bree R;de Keizer B;Civantos FJ;Takes RP;Rodrigo JP;Hernandez-Prera JC;Halmos GB;Rinaldo A;Ferlito A
通讯作者:
Ferlito A
影响因子:
4.6
作者:
Li G;Li X;Yang M;Xu L;Deng S;Ran L
通讯作者:
Ran L
影响因子:
6.1
作者:
Jia, Yanyan;Shi, Huirong;Li, Xueru
通讯作者:
Li, Xueru
影响因子:
7.8
作者:
Abu-Ghanem, Sara;Yehuda, Moshe;Fliss, Dan M.
通讯作者:
Fliss, Dan M.